Skip to main content
. 2017 Jul 30;2017(7):CD000254. doi: 10.1002/14651858.CD000254.pub4

Comparison 1. Antioxidant multivitamin and mineral supplement versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Progression to late AMD (neovascular AMD or geographic atrophy) 3 2445 Odds Ratio (Fixed, 95% CI) 0.72 [0.58, 0.90]
2 Progression to neovascular AMD 1   Odds Ratio (Fixed, 95% CI) Totals not selected
3 Progression to geographic atrophy 1   Odds Ratio (Fixed, 95% CI) Totals not selected
4 Progression to visual loss (loss of 3 or more lines on logMAR chart) 1   Odds Ratio (Fixed, 95% CI) Totals not selected
5 Mean visual acuity 5 595 Mean Difference (IV, Fixed, 95% CI) 0.02 [‐0.03, 0.07]
5.1 Mean visual acuity at end of study 1 59 Mean Difference (IV, Fixed, 95% CI) 0.04 [‐0.13, 0.21]
5.2 Change in visual acuity 4 536 Mean Difference (IV, Fixed, 95% CI) 0.02 [‐0.03, 0.07]
6 Quality of life 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected